These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9226696)

  • 1. Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy.
    Dutra WO; da Luz ZM; Cançado JR; Pereira ME; Brigido-Nunes RM; Galvão LM; Colley DG; Brener Z; Gazzinelli G; Carvalho-Parra JF
    Parasite Immunol; 1996 Nov; 18(11):579-85. PubMed ID: 9226696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
    Alessio GD; Côrtes DF; Machado de Assis GF; Júnior PA; Ferro EA; Antonelli LR; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
    J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease.
    Albareda MC; Natale MA; Cesar GL; Castro Eiro MD; Alvarez MG; Laucella SA
    Methods Mol Biol; 2019; 1955():339-348. PubMed ID: 30868539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively.
    Dutra WO; Colley DG; Pinto-Dias JC; Gazzinelli G; Brener Z; Pereira ME; Coffman RL; Correa-Oliveira R; Carvalho-Parra JF
    Scand J Immunol; 2000 Jan; 51(1):91-7. PubMed ID: 10632982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen.
    de Barros-Mazon S; Guariento ME; Abrahamsohn IA
    Immunol Lett; 1997 Jun; 57(1-3):39-45. PubMed ID: 9232423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells.
    Mosca W; Briceño L; Hernández MI
    Mem Inst Oswaldo Cruz; 1991; 86(2):147-52. PubMed ID: 1842408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
    Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
    J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.
    Villanueva-Lizama LE; Cruz-Chan JV; Aguilar-Cetina ADC; Herrera-Sanchez LF; Rodriguez-Perez JM; Rosado-Vallado ME; Ramirez-Sierra MJ; Ortega-Lopez J; Jones K; Hotez P; Bottazzi ME; Dumonteil E
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006240. PubMed ID: 29377898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
    Van Voorhis WC
    J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytes.
    Kierszenbaum F; Mejia Lopez H; Tanner MK; Sztein MB
    Parasite Immunol; 1995 Apr; 17(4):207-14. PubMed ID: 7624161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins.
    Krautz GM; Peterson JD; Godsel LM; Krettli AU; Engman DM
    Am J Trop Med Hyg; 1998 Feb; 58(2):137-43. PubMed ID: 9502594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 production in patients with Chagas' disease: correlation with anti-parasite antibody responses.
    Tarleton RL; de Andrade PP; de Andrade CR
    Immunol Lett; 1988 Mar; 17(3):229-34. PubMed ID: 3131236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of accessory cells in the Trypanosoma cruzi-induced inhibition of the polyclonal response of T lymphocytes.
    Motrán C; Gruppi A; Vullo CM; Pistoresi-Palencia MC; Serra HM
    Parasite Immunol; 1996 Jan; 18(1):43-8. PubMed ID: 9223155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Mattoso-Barbosa AM; Gouin N; Perdigão-de-Oliveira M; Valério-Dos-Reis L; Costa RP; Elói-Santos SM; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; Dick EJ; Hubbard GB; VandeBerg JF; VandeBerg JL
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005233. PubMed ID: 28225764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease.
    Dutra WO; Martins-Filho OA; Cançado JR; Pinto-Dias JC; Brener Z; Freeman Júnior GL; Colley DG; Gazzinelli G; Parra JC
    Int Immunol; 1994 Apr; 6(4):499-506. PubMed ID: 8018591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
    Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.